Fahad Khaliq/X
Jan 7, 2026, 08:50
Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
Fahad Khaliq, Doctor of Medicine at Allied Hospital, Faisalabad, reposted from Muhammad Moor on X:
”Faster, potent, better, reversible, better mortality results
But here’s the plot twist!
If a patient is already on anticoagulation/high risk bleed, Clopidogrel is preferred
Rule of thumb:
• STEMI pt undergoing PCI: Ticagrelor
• STEMI pt undergoing Thrombolysis: Clopidogrel”
Quoting Muhammad Moor‘s post:
”Why is Ticagrelor sometimes preferred over other antiplatelets in acute coronary syndrome (ACS)?”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026